psilocybin has been researched along with Drug Withdrawal Symptoms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, BT; Averill, LA; Belouin, SJ; Berger, A; Danforth, AL; Donato, I; Grob, CS; Henningfield, JE; Magar, V; Xenakis, SN | 1 |
| Jones, G; Lipson, J; Wang, E | 1 |
| Garcia-Romeu, A; Griffiths, RR; Johnson, MW; Noorani, T; Swift, TC | 1 |
| Ross, S | 1 |
1 review(s) available for psilocybin and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.
Topics: Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Policy; Psilocybin; Substance Withdrawal Syndrome | 2022 |
3 other study(ies) available for psilocybin and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample.
Topics: Adult; Hallucinogens; Humans; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Social Interaction; Substance Withdrawal Syndrome | 2023 |
Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts.
Topics: Adult; Aged; Female; Follow-Up Studies; Hallucinogens; Humans; Interviews as Topic; Male; Middle Aged; Pilot Projects; Psilocybin; Retrospective Studies; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2018 |
Serotonergic hallucinogens and emerging targets for addiction pharmacotherapies.
Topics: Adult; Animals; Behavior, Addictive; Clinical Trials as Topic; Cognition; Dopamine; Dopamine Agonists; Glutamates; Hallucinogens; Humans; Ibogaine; Lysergic Acid; Neuronal Plasticity; Nucleus Accumbens; Phytotherapy; Prefrontal Cortex; Psilocybin; Religion; Reward; Serotonin 5-HT2 Receptor Agonists; Substance Withdrawal Syndrome; Substance-Related Disorders | 2012 |